COVID Catch-Up
08/17 News Flash 1: Encouraging results from the BioNTech/Pfizer vaccine candidate
Image courtesy of Wikimedia Commons. Results from a Phase 1/2 study of COVID-19 RNA vaccine candidate, BNT162b1, support its safety and immunogenicity. The observer-blinded study